2nd Quarter - Report

MILLER STRATEGIES, LLC for ALZHEON, INC.

Firm
Client
Income
$180,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues related to FDA drug approval process and therapies for Alzheimer's disease.

LobbyistCovered position, as disclosed
ASHLEY GUNN —
JEFFREY MILLER —
JAMES MIN —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Health Issues HCR

Issues related to FDA drug approval process and therapies for Alzheimer's disease.

LobbyistCovered position, as disclosed
ASHLEY GUNN —
JEFFREY MILLER —
JAMES MIN —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.